Abstract

The hypothalamus-pituitary-adrenal (HPA) axis is activated in response to inflammation leading to increased production of anti-inflammatory glucocorticoids by the adrenal cortex, thereby representing an endogenous feedback loop. However, severe inflammation reduces the responsiveness of the adrenal gland to adrenocorticotropic hormone (ACTH), although the underlying mechanisms are poorly understood. Here, we show by transcriptomic, proteomic and metabolomic analyses that LPS-induced systemic inflammation triggers profound metabolic changes in steroidogenic adrenocortical cells, including downregulation of the TCA cycle and oxidative phosphorylation, in mice. Inflammation disrupts the TCA cycle at the level of succinate dehydrogenase (SDH), leading to succinate accumulation and disturbed steroidogenesis. Mechanistically, IL-1β reduces SDHB expression through upregulation of DNA methyltransferase 1 (DNMT1) and methylation of the SDHB promoter. Consequently, increased succinate levels impair oxidative phosphorylation and ATP synthesis and enhance ROS production, leading to reduced steroidogenesis. Together, we demonstrate that the IL-1β-DNMT1-SDHB-succinate axis disrupts steroidogenesis. Our findings not only provide a mechanistic explanation for the adrenal dysfunction in severe inflammation, but also offer a potential target for therapeutic intervention.

Data availability

RNA-Seq data are available in: https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE200220.The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository, with the dataset identifier PXD036542. Once the article is accepted, data will be made public and accessible.

The following data sets were generated

Article and author information

Author details

  1. Ivona Mateska

    Institute of Clinical Chemistry and Laboratory Medicine, TU Dresden, Dresden, Germany
    For correspondence
    Ivona.Mateska@uniklinikum-dresden.de
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6150-9175
  2. Anke Witt

    Institute of Clinical Chemistry and Laboratory Medicine, TU Dresden, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
  3. Eman Hagag

    Institute of Clinical Chemistry and Laboratory Medicine, TU Dresden, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
  4. Anupam Sinha

    Institute of Clinical Chemistry and Laboratory Medicine, TU Dresden, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
  5. Canelif Yilmaz

    Institute of Clinical Chemistry and Laboratory Medicine, TU Dresden, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9676-9310
  6. Evangelia Thanou

    Department of Molecular and Cellular Neurobiology, Vrije Universiteit, Amsterdam, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6843-4591
  7. Na Sun

    Research Unit Analytical Pathology, Helmholtz Zentrum München, Neuherberg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  8. Ourania Kolliniati

    Department of Clinical Chemistry, University of Crete, Heraklion, Greece
    Competing interests
    The authors declare that no competing interests exist.
  9. Maria Patschin

    Institute for Clinical Chemistry and Laboratory Medicine, TU Dresden, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
  10. Heba Abdelmegeed

    Institute for Clinical Chemistry and Laboratory Medicine, TU Dresden, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
  11. Holger Henneicke

    enter for Regenerative Therapies, TU Dresden, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
  12. Waldemar Kanczkowski

    Institute for Clinical Chemistry and Laboratory Medicine, TU Dresden, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
  13. Ben Wielockx

    Institute for Clinical Chemistry and Laboratory Medicine, TU Dresden, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
  14. Christos Tsatsanis

    Department of Clinical Chemistry, University of Crete, Heraklion, Greece
    Competing interests
    The authors declare that no competing interests exist.
  15. Andreas Dahl

    Center for Molecular and Cellular Bioengineering, TU Dresden, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2668-8371
  16. Axel Karl Walch

    Research Unit Analytical Pathology, Helmholtz Zentrum München, Munich, Germany
    Competing interests
    The authors declare that no competing interests exist.
  17. Ka Wan Li

    Center of Neurogenomics and Cognitive Research, Vrije Universiteit, Amsterdam, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6983-5055
  18. Mirko Peitzsch

    Institute of Clinical Chemistry and Laboratory Medicine, TU Dresden, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2472-675X
  19. Triantafyllos Chavakis

    Institute of Clinical Chemistry and Laboratory Medicine, TU Dresden, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
  20. Vasileia Ismini Alexaki

    Institute of Clinical Chemistry and Laboratory Medicine, TU Dresden, Dresden, Germany
    For correspondence
    VasileiaIsmini.Alexaki@uniklinikum-dresden.de
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3935-8985

Funding

Deutsche Forschungsgemeinschaft (SFB/TRR205)

  • Ben Wielockx
  • Mirko Peitzsch
  • Vasileia Ismini Alexaki

HORIZON EUROPE Framework Programme (Marie Skłodowska-Curie grant agreement No 765704)

  • Vasileia Ismini Alexaki

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: The animal experiments were approved by the Landesdirektion Sachsen Germany (protocol number TVV57/2018).

Copyright

© 2023, Mateska et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 8
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Ivona Mateska
  2. Anke Witt
  3. Eman Hagag
  4. Anupam Sinha
  5. Canelif Yilmaz
  6. Evangelia Thanou
  7. Na Sun
  8. Ourania Kolliniati
  9. Maria Patschin
  10. Heba Abdelmegeed
  11. Holger Henneicke
  12. Waldemar Kanczkowski
  13. Ben Wielockx
  14. Christos Tsatsanis
  15. Andreas Dahl
  16. Axel Karl Walch
  17. Ka Wan Li
  18. Mirko Peitzsch
  19. Triantafyllos Chavakis
  20. Vasileia Ismini Alexaki
(2023)
Succinate mediates inflammation-induced adrenocortical dysfunction
eLife 12:e83064.
https://doi.org/10.7554/eLife.83064

Share this article

https://doi.org/10.7554/eLife.83064

Further reading

    1. Cell Biology
    Chengfang Pan, Ying Liu ... Changlong Hu
    Research Article

    Prostaglandin E2 (PGE2) is an endogenous inhibitor of glucose-stimulated insulin secretion (GSIS) and plays an important role in pancreatic β-cell dysfunction in type 2 diabetes mellitus (T2DM). This study aimed to explore the underlying mechanism by which PGE2 inhibits GSIS. Our results showed that PGE2 inhibited Kv2.2 channels via increasing PKA activity in HEK293T cells overexpressed with Kv2.2 channels. Point mutation analysis demonstrated that S448 residue was responsible for the PKA-dependent modulation of Kv2.2. Furthermore, the inhibitory effect of PGE2 on Kv2.2 was blocked by EP2/4 receptor antagonists, while mimicked by EP2/4 receptor agonists. The immune fluorescence results showed that EP1–4 receptors are expressed in both mouse and human β-cells. In INS-1(832/13) β-cells, PGE2 inhibited voltage-gated potassium currents and electrical activity through EP2/4 receptors and Kv2.2 channels. Knockdown of Kcnb2 reduced the action potential firing frequency and alleviated the inhibition of PGE2 on GSIS in INS-1(832/13) β-cells. PGE2 impaired glucose tolerance in wild-type mice but did not alter glucose tolerance in Kcnb2 knockout mice. Knockout of Kcnb2 reduced electrical activity, GSIS and abrogated the inhibition of PGE2 on GSIS in mouse islets. In conclusion, we have demonstrated that PGE2 inhibits GSIS in pancreatic β-cells through the EP2/4-Kv2.2 signaling pathway. The findings highlight the significant role of Kv2.2 channels in the regulation of β-cell repetitive firing and insulin secretion, and contribute to the understanding of the molecular basis of β-cell dysfunction in diabetes.

    1. Cell Biology
    Ryan M Finnerty, Daniel J Carulli ... Wipawee Winuthayanon
    Research Article

    The oviduct is the site of fertilization and preimplantation embryo development in mammals. Evidence suggests that gametes alter oviductal gene expression. To delineate the adaptive interactions between the oviduct and gamete/embryo, we performed a multi-omics characterization of oviductal tissues utilizing bulk RNA-sequencing (RNA-seq), single-cell RNA-sequencing (scRNA-seq), and proteomics collected from distal and proximal at various stages after mating in mice. We observed robust region-specific transcriptional signatures. Specifically, the presence of sperm induces genes involved in pro-inflammatory responses in the proximal region at 0.5 days post-coitus (dpc). Genes involved in inflammatory responses were produced specifically by secretory epithelial cells in the oviduct. At 1.5 and 2.5 dpc, genes involved in pyruvate and glycolysis were enriched in the proximal region, potentially providing metabolic support for developing embryos. Abundant proteins in the oviductal fluid were differentially observed between naturally fertilized and superovulated samples. RNA-seq data were used to identify transcription factors predicted to influence protein abundance in the proteomic data via a novel machine learning model based on transformers of integrating transcriptomics and proteomics data. The transformers identified influential transcription factors and correlated predictive protein expressions in alignment with the in vivo-derived data. Lastly, we found some differences between inflammatory responses in sperm-exposed mouse oviducts compared to hydrosalpinx Fallopian tubes from patients. In conclusion, our multi-omics characterization and subsequent in vivo confirmation of proteins/RNAs indicate that the oviduct is adaptive and responsive to the presence of sperm and embryos in a spatiotemporal manner.